Shareholding disclosure

Timothy Dyer

Declared position

11.55%

Threshold

Crossed upwards

Timeline

Published

08.06.2018

Transaction

01.06.2018

Transfer date

01.06.2018

Voting rights breakdown

Voting rights acquired11.55%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAI66000B3

Beneficial owner

Timothy Dyer

Declared address

Timothy Dyer, CH1196 Gland

Timothy Dyer is the 100% shareholder of TMD Advisory SARL

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Timothy Dyer

Addex Therapeutics Ltd08.06.2018TAI66000B3

Disclosure summary

Timothy Dyer disclosed a holding in Addex Therapeutics Ltd on the acquisition side, published by SIX Exchange Regulation on 08.06.2018, at 11.55% of voting rights. Notice category: Single shareholder.

Disclosed position

11.55%

Voting rights acquired

Voting rights acquired11.55%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Timothy Dyer disclosed a holding in Addex Therapeutics Ltd, published on 08.06.2018.

Publication date08.06.2018

Transaction date01.06.2018

Transfer date01.06.2018

Issuing companyAddex Therapeutics Ltd

Beneficial ownerTimothy Dyer

Declared addressTimothy Dyer, CH1196 Gland

CategorySingle shareholder

Voting rights acquired11.55%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAI66000B3

Conditions

Timothy Dyer is the 100% shareholder of TMD Advisory SARL

Source: SIX Exchange Regulation · Publication date: 08.06.2018

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open